Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management named NVIDIA Corporation (NASDAQ:NVDA) as her final trade.

NVIDIA recently announced a 10-for-1 stock split. The semiconductor giant revealed this decision during its recent quarterly earnings report. The split-adjusted trading commenced on Monday, June 10.

Jim Lebenthal of Cerity Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), which is a biopharmaceutical company.

On Friday, Vertex revealed positive long-term data on CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress.

Don't forget to check out our premarket coverage here

Kevin Simpson of Capital Wealth Planning named ConocoPhillips (NYSE:COP), saying the acquisition of Marathon Oil Corporation (NYSE:MRO) will be aggregate over time.

On Friday, BofA Securities analyst Kalei Akamine reinstated ConocoPhillips with a Buy rating and announced a price target of $147.

Rob Sechan of NewEdge Wealth said AbbVie Inc. (NYSE:ABBV) has an attractive valuation, wonderful pipeline and a great yield.

On June 6, AbbVie released topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab soravtansine (Elahere) monotherapy in heavily pre-treated patients with folate receptor-alpha (FRα) positive, platinum-sensitive ovarian cancer (PSOC). The study met its primary endpoint with an objective response rate (ORR) of 51.9%.

Price Action:

• Nvidia shares gained 1.8% to close at $131.88 during Friday's session.
• Vertex Pharmaceuticals shares rose 0.4% to close at $480.73 on Friday.
• ConocoPhillips shares fell 1.4% to settle at $109.39 during Friday's session.
• AbbVie gained 1.2% to close at $168.59 on Friday.

Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Tech Stocks With Over 3% Dividend Yields

Image generated using artificial intelligence via Midjourney.